Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05109065 · ClinicalTrials.gov registry record
Peripheral Immune System in Individuals With Schizophrenia
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 63
- Enrollment target
NCT05109065: Completed study, sponsored by Stanford University.
NCT05109065 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05109065 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
The investigators are seeking healthy volunteers and people with schizophrenia or schizoaffective disorder for a clinical study of the immune system in psychotic disorders. This is an observational study, to understand the ways in which the immune system may be contributing to the disease process.
Interventions
- DIAGNOSTIC_TEST Vitals
- DIAGNOSTIC_TEST SCID (Standardized Clinical Interview for DSM-V)
- DIAGNOSTIC_TEST PSS (Perceived Stress Score)
- DIAGNOSTIC_TEST Urine Toxicology Screen
- DIAGNOSTIC_TEST Blood Work
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2024-05-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05109065
The ClinicalTrials.gov registry entry for NCT05109065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vitals is the first listed.
NCT05109065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05109065 about?
NCT05109065 is a clinical study titled "Peripheral Immune System in Individuals With Schizophrenia". The investigators are seeking healthy volunteers and people with schizophrenia or schizoaffective disorder for a clinical study of the immune system in psychotic disorders. This is an observational study, to understand the ways in which the immune system may be contributing to the disease process.
What is the current status of trial NCT05109065?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2021-03-01. Estimated completion is 2024-05-23.
What interventions are being tested in trial NCT05109065?
The interventions under investigation include: Vitals (DIAGNOSTIC_TEST), SCID (Standardized Clinical Interview for DSM-V) (DIAGNOSTIC_TEST), PSS (Perceived Stress Score) (DIAGNOSTIC_TEST), Urine Toxicology Screen (DIAGNOSTIC_TEST), Blood Work (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05109065?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.